- Home
- NIE vs SRDX Comparison
NIE vs SRDX Comparison
Compare NIE & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIE
- SRDX
- Stock Information
- Founded
- NIE 2007
- SRDX 1979
- Country
- NIE United States
- SRDX United States
- Employees
- NIE N/A
- SRDX N/A
- Industry
- NIE Investment Managers
- SRDX Medical/Dental Instruments
- Sector
- NIE Finance
- SRDX Health Care
- Exchange
- NIE Nasdaq
- SRDX Nasdaq
- Market Cap
- NIE 694.9M
- SRDX 562.6M
- IPO Year
- NIE N/A
- SRDX 1998
- Fundamental
- Price
- NIE $23.99
- SRDX $39.70
- Analyst Decision
- NIE
- SRDX Hold
- Analyst Count
- NIE 0
- SRDX 4
- Target Price
- NIE N/A
- SRDX $43.00
- AVG Volume (30 Days)
- NIE 70.5K
- SRDX 171.3K
- Earning Date
- NIE 01-01-0001
- SRDX 01-30-2025
- Dividend Yield
- NIE 9.04%
- SRDX N/A
- EPS Growth
- NIE N/A
- SRDX N/A
- EPS
- NIE N/A
- SRDX N/A
- Revenue
- NIE N/A
- SRDX $126,078,000.00
- Revenue This Year
- NIE N/A
- SRDX $13.75
- Revenue Next Year
- NIE N/A
- SRDX $13.67
- P/E Ratio
- NIE N/A
- SRDX N/A
- Revenue Growth
- NIE N/A
- SRDX N/A
- 52 Week Low
- NIE $18.61
- SRDX $25.17
- 52 Week High
- NIE $22.47
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- NIE 52.49
- SRDX 62.80
- Support Level
- NIE $24.32
- SRDX $39.59
- Resistance Level
- NIE $24.77
- SRDX $40.39
- Average True Range (ATR)
- NIE 0.34
- SRDX 0.32
- MACD
- NIE -0.09
- SRDX -0.03
- Stochastic Oscillator
- NIE 25.19
- SRDX 59.17
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments such as aerospace and defense, banks, IT services, software, and others.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.